Cargando…
Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study
BACKGROUND: Reasons for and frequency of nonadherence to antiretroviral therapy (ART) may have changed due to pharmacological improvements. In addition, the importance of known non-pharmacologic reasons for nonadherence is unclear. METHODS: We performed a cross-sectional, noninterventional, multicen...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687417/ https://www.ncbi.nlm.nih.gov/pubmed/29184394 http://dx.doi.org/10.2147/PPA.S141762 |
_version_ | 1783278953613492224 |
---|---|
author | Boretzki, Johanna Wolf, Eva Wiese, Carmen Noe, Sebastian Balogh, Annamaria Meurer, Anja Krznaric, Ivanka Zink, Alexander Lersch, Christian Spinner, Christoph D |
author_facet | Boretzki, Johanna Wolf, Eva Wiese, Carmen Noe, Sebastian Balogh, Annamaria Meurer, Anja Krznaric, Ivanka Zink, Alexander Lersch, Christian Spinner, Christoph D |
author_sort | Boretzki, Johanna |
collection | PubMed |
description | BACKGROUND: Reasons for and frequency of nonadherence to antiretroviral therapy (ART) may have changed due to pharmacological improvements. In addition, the importance of known non-pharmacologic reasons for nonadherence is unclear. METHODS: We performed a cross-sectional, noninterventional, multicenter study to identify current reasons for nonadherence. Patients were categorized by physicians into the following adherence groups: good, unstable, or poor adherence. Co-variables of interest included age, sex, time since HIV diagnosis, ART duration, current ART regimen, HIV transmission route, comorbidity, HIV-1 RNA viral load (VL), and CD4 cell count. Patients self-reported the number of missed doses and provided their specific reasons for nonadherent behavior. Statistical analyses were performed using Fisher’s extended exact test, Kruskal–Wallis test, and logistic regression models. RESULTS: Our study assessed 215 participants with good (n=162), unstable (n=36), and poor adherence (n=17). Compared to patients with good adherence, patients with unstable and poor adherence reported more often to have missed at least one dose during the last week (good 11% vs unstable 47% vs poor 63%, p<0.001). Physicians’ adherence assessment was concordant with patients’ self-reports of missed doses during the last week (no vs one or more) in 81% cases. Similarly, we found a strong association of physicians’ assessment with viral suppression. Logistic regression analysis showed that “reduced adherence” – defined as unstable or poor – was significantly associated with patients <30 years old, intravenous drug use, history of acquired immune deficiency syndrome (AIDS), and psychiatric disorders (p<0.05). Univariate analyses showed that specific reasons, such as questioning the efficacy/dosing of ART, HIV stigma, interactive toxicity beliefs regarding alcohol and/or party drugs, and dissatisfaction with regimen complexity, correlated with unstable or poor adherence (p<0.05). CONCLUSION: Identification of factors associated with poor adherence helps in identifying patients with a higher risk for nonadherence. Reasons for nonadherence should be directly addressed in every patient, because they are common and constitute possible adherence intervention points. |
format | Online Article Text |
id | pubmed-5687417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56874172017-11-28 Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study Boretzki, Johanna Wolf, Eva Wiese, Carmen Noe, Sebastian Balogh, Annamaria Meurer, Anja Krznaric, Ivanka Zink, Alexander Lersch, Christian Spinner, Christoph D Patient Prefer Adherence Original Research BACKGROUND: Reasons for and frequency of nonadherence to antiretroviral therapy (ART) may have changed due to pharmacological improvements. In addition, the importance of known non-pharmacologic reasons for nonadherence is unclear. METHODS: We performed a cross-sectional, noninterventional, multicenter study to identify current reasons for nonadherence. Patients were categorized by physicians into the following adherence groups: good, unstable, or poor adherence. Co-variables of interest included age, sex, time since HIV diagnosis, ART duration, current ART regimen, HIV transmission route, comorbidity, HIV-1 RNA viral load (VL), and CD4 cell count. Patients self-reported the number of missed doses and provided their specific reasons for nonadherent behavior. Statistical analyses were performed using Fisher’s extended exact test, Kruskal–Wallis test, and logistic regression models. RESULTS: Our study assessed 215 participants with good (n=162), unstable (n=36), and poor adherence (n=17). Compared to patients with good adherence, patients with unstable and poor adherence reported more often to have missed at least one dose during the last week (good 11% vs unstable 47% vs poor 63%, p<0.001). Physicians’ adherence assessment was concordant with patients’ self-reports of missed doses during the last week (no vs one or more) in 81% cases. Similarly, we found a strong association of physicians’ assessment with viral suppression. Logistic regression analysis showed that “reduced adherence” – defined as unstable or poor – was significantly associated with patients <30 years old, intravenous drug use, history of acquired immune deficiency syndrome (AIDS), and psychiatric disorders (p<0.05). Univariate analyses showed that specific reasons, such as questioning the efficacy/dosing of ART, HIV stigma, interactive toxicity beliefs regarding alcohol and/or party drugs, and dissatisfaction with regimen complexity, correlated with unstable or poor adherence (p<0.05). CONCLUSION: Identification of factors associated with poor adherence helps in identifying patients with a higher risk for nonadherence. Reasons for nonadherence should be directly addressed in every patient, because they are common and constitute possible adherence intervention points. Dove Medical Press 2017-11-08 /pmc/articles/PMC5687417/ /pubmed/29184394 http://dx.doi.org/10.2147/PPA.S141762 Text en © 2017 Boretzki et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Boretzki, Johanna Wolf, Eva Wiese, Carmen Noe, Sebastian Balogh, Annamaria Meurer, Anja Krznaric, Ivanka Zink, Alexander Lersch, Christian Spinner, Christoph D Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study |
title | Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study |
title_full | Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study |
title_fullStr | Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study |
title_full_unstemmed | Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study |
title_short | Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study |
title_sort | highly specific reasons for nonadherence to antiretroviral therapy: results from the german adherence study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687417/ https://www.ncbi.nlm.nih.gov/pubmed/29184394 http://dx.doi.org/10.2147/PPA.S141762 |
work_keys_str_mv | AT boretzkijohanna highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT wolfeva highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT wiesecarmen highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT noesebastian highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT baloghannamaria highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT meureranja highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT krznaricivanka highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT zinkalexander highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT lerschchristian highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy AT spinnerchristophd highlyspecificreasonsfornonadherencetoantiretroviraltherapyresultsfromthegermanadherencestudy |